• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

There is increasing evidence that genome-wide association (GWA) studies represent a powerful approach to the identification of genes involved in common human diseases. We describe a joint GWA study (using the Affymetrix GeneChip 500K Mapping Array Set) undertaken in the British population, which has examined approximately 2,000 individuals for each of 7 major diseases and a shared set of approximately 3,000 controls. Case-control comparisons identified 24 independent association signals at P < 5 x 10(-7): 1 in bipolar disorder, 1 in coronary artery disease, 9 in Crohn's disease, 3 in rheumatoid arthritis, 7 in type 1 diabetes and 3 in type 2 diabetes. On the basis of prior findings and replication studies thus-far completed, almost all of these signals reflect genuine susceptibility effects. We observed association at many previously identified loci, and found compelling evidence that some loci confer risk for more than one of the diseases studied. Across all diseases, we identified a large number of further signals (including 58 loci with single-point P values between 10(-5) and 5 x 10(-7)) likely to yield additional susceptibility loci. The importance of appropriately large samples was confirmed by the modest effect sizes observed at most loci identified. This study thus represents a thorough validation of the GWA approach. It has also demonstrated that careful use of a shared control group represents a safe and effective approach to GWA analyses of multiple disease phenotypes; has generated a genome-wide genotype database for future studies of common diseases in the British population; and shown that, provided individuals with non-European ancestry are excluded, the extent of population stratification in the British population is generally modest. Our findings offer new avenues for exploring the pathophysiology of these important disorders. We anticipate that our data, results and software, which will be widely available to other investigators, will provide a powerful resource for human genetics research.

Pubmed ID: 17554300

Authors

  • Wellcome Trust Case Control Consortium

Journal

Nature

Publication Data

June 7, 2007

Associated Grants

  • Agency: Wellcome Trust, Id: 076113
  • Agency: Wellcome Trust, Id: 077011
  • Agency: Wellcome Trust, Id: 090532
  • Agency: Chief Scientist Office, Id: CZB/4/540
  • Agency: Chief Scientist Office, Id: ETM/137
  • Agency: Chief Scientist Office, Id: ETM/75
  • Agency: Medical Research Council, Id: G0000934
  • Agency: Medical Research Council, Id: G0100594
  • Agency: Medical Research Council, Id: G0501942
  • Agency: Medical Research Council, Id: G0600329
  • Agency: Medical Research Council, Id: G0600705
  • Agency: Medical Research Council, Id: G0800759
  • Agency: Medical Research Council, Id: G0901461
  • Agency: Medical Research Council, Id: G19/9
  • Agency: Medical Research Council, Id: G90/106
  • Agency: Medical Research Council, Id: G9806740
  • Agency: Medical Research Council, Id: G9810900
  • Agency: Medical Research Council, Id: G9817803B
  • Agency: Wellcome Trust, Id:

Mesh Terms

  • Arthritis, Rheumatoid
  • Bipolar Disorder
  • Case-Control Studies
  • Chromosomes, Human
  • Coronary Artery Disease
  • Crohn Disease
  • Diabetes Mellitus
  • Gene Frequency
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Genetics, Population
  • Genome, Human
  • Geography
  • Great Britain
  • Humans
  • Hypertension